Amerigroup Reports Second Quarter 2011 Results

Net Income of $44.3 Million or $0.83 per Diluted Share

VIRGINIA BEACH, Va., July 29, 2011 /PRNewswire/ -- Amerigroup Corporation (NYSE: AGP) today announced that net income for the second quarter of 2011 was $44.3 million, or $0.83 per diluted share, versus net income of $67.2 million, or $1.31 per diluted share, for the second quarter of 2010 and compared to $70.5 million, or $1.37 per diluted share, for the first quarter of 2011.  Total revenues for the second quarter were $1.53 billion, a 6.3% increase versus $1.44 billion in the second quarter of 2010 and compared to $1.54 billion in the first quarter of 2011.

Second quarter 2011 results were negatively impacted by a retroactive premium adjustment in the State of Georgia of approximately $13.8 million, or $0.16 per diluted share.  

Highlights include:

  • Membership increased 15,000 members, or 0.8%, to approximately 2.0 million at the end of the second quarter compared to the first quarter of 2011.  
  • Health benefits expense was 84.1% of premium revenue for the second quarter of 2011.  
  • Selling, general and administrative expenses were 8.0% of total revenues for the second quarter of 2011.
  • Cash flow provided by operations was $31 million and $115 million for the three and six months ended June 30, 2011, respectively.
  • Unregulated cash and investments were $255 million as of June 30, 2011 compared to $269 million as of March 31, 2011.
  • Medical claims payable as of June 30, 2011 totaled $520 million compared to $540 million as of March 31, 2011.
  • Days in claims payable was 37, compared to 39 days in the first quarter of 2011.
  • The Company repurchased approximately 815,000 shares of its common stock during the second quarter, at an aggregate cost of $55.2 million, pursuant to its ongoing share repurchase program.  
  • On July 25, 2011, the Louisiana Department of Health and Hospitals announced that Amerigroup was one of five managed care organizations selected through competitive procurement to offer healthcare coverage to Medicaid recipients in Louisiana. The State indicated that the managed care organizations will enroll collectively approximately 900,000 members statewide, including children and families served by Medicaid's Temporary Assistance for Needy Families (TANF) as well as people with disabilities.  Of the five managed care organizations selected, the Company is one of three providers that will offer services on a full-risk basis.  Pending final contract negotiations, the Company anticipates beginning operations in early 2012.

"We are pleased with the underlying results in the quarter.  Excluding prior period items, second quarter performance was in-line with our expectations," said James G. Carlson, Chairman and CEO of Amerigroup.  "Furthermore, we are delighted that Louisiana has selected us to serve low-income citizens through its new Medicaid Coordinated Care Network. For the last 17 years, we have developed innovative initiatives to help our members live healthier lives and at the same time lower healthcare costs for states."

Premium Revenue

Premium revenue for the second quarter of 2011 increased 6.6% to $1.52 billion versus $1.43 billion in the second quarter of 2010.  Sequentially, premium revenue decreased $12.4 million, or 0.8%.  

Premium revenue in the second quarter was negatively impacted by approximately $13.8 million due to a retroactive premium adjustment in the State of Georgia related to a reconciliation of duplicate member records.  This premium adjustment reduced diluted earnings per share by $0.16.

The Company recently identified anomalies in the Georgia monthly membership files indicating that the State was not current in its process of merging duplicate member records. For various reasons, it is common for the State to assign members more than one Medicaid number, which results in multiple member records and duplicate premium payments for the same member.  In normal course, the State attempts to correct these duplicate member records in a timely manner.

Based on the Company's inquiry to the State regarding the volume of anomalies in the monthly membership files, Georgia's Department of Community Health initiated a comprehensive review that uncovered systemic membership record problems impacting contracted health plans as far back as the start of the program in 2006.  Following its review, the State notified the health plans of the premium the State believes should be returned due to duplicate payments.  The Company has established an estimated liability for premium payments that it believes will be returned to the State during this process.

In addition, these overstated membership files were used by the State to determine the per member premium rates paid to health plans over numerous contract years.  Inclusion of these duplicate members resulted in lower per member rates for those years and, as a result, the Company expects that these historical premium rate calculations will be revisited to adjust the per member rates upward. While the Company has been advised that the State intends to address these premium rate issues through settlement agreements with the health plans, the Company has not established a receivable for any such amount because, in the Company's opinion, any settlement value cannot be estimated with an adequate level of precision at this time.

Premium revenue for the quarter was also compressed by accruals for experience rebate in Texas, applicable medical loss ratio floors, and other gain sharing arrangements with State customers, as well as other routine prior period revenue adjustments that, on balance, were slightly negative.

Investment Income and Other Revenues

Second quarter investment income and other revenues were $4.0 million versus $8.6 million in the second quarter of 2010, and compared to $4.1 million in the first quarter of 2011.  As previously reported, in the second quarter of 2010 investment income and other revenues included $4.0 million related to the sale of a trademark.  

Health Benefits

Health benefits expense, as a percent of premium revenue, was 84.1% for the second quarter of 2011 versus 82.3% in the second quarter of 2010, and compared to 81.8% in the first quarter of 2011.  

The sequential increase in the health benefits ratio was due in part to the retroactive premium adjustment in Georgia that unfavorably impacted the health benefits ratio by 80 basis points.  

Favorable reserve development (net of associated accruals for experience rebate in Texas, applicable medical loss ratio floors, and other gain sharing arrangements with State customers) positively impacted the health benefits ratio in the second quarter by 50 basis points compared to 140 basis points in the first quarter of 2011.  

While medical cost trends remained modest during the quarter relative to long-term norms, there are emerging signs that trends have begun to move up from the unusually low levels experienced in prior quarters.

Selling, General and Administrative Expenses

Selling, general and administrative expenses were 8.0% of total revenues for the second quarter of 2011 versus 7.5% in the second quarter of 2010, and compared to 7.6% for the first quarter of 2011.  Selling, general and administrative expenses increased sequentially, primarily due to scheduled compensation increases which were consistent with Company expectations.

Premium Taxes

Second quarter premium taxes were $40.4 million versus $33.2 million for the second quarter of 2010, and compared to $40.4 million in the first quarter of 2011.  

Balance Sheet Highlights

Cash and investments at June 30, 2011 totaled $1.84 billion of which $255 million was unregulated compared to $269 million of unregulated cash and investments at March 31, 2011.  During the quarter, the Company repurchased approximately 815,000 shares of its common stock at an aggregate cost of $55.2 million, pursuant to its ongoing share repurchase program.  

The debt-to-total-capital ratio decreased to 16.6% as of June 30, 2011 from 16.8% as of March 31, 2011.

Medical claims payable as of June 30, 2011 totaled $520 million compared to $540 million as of March 31, 2011.  Days in claims payable represented 37 days of health benefits expense compared with 39 days in the previous quarter.  The primary factor that drove the decline in days in claims payable was an increase in claims processing speed aided in part by an increase in the claims auto-adjudication rate.  

Included on page 11 is a table presenting the components of the change in medical claims payable for each of the six-month periods ended June 30, 2011 and 2010.  

Cash Flow Highlights

Cash flow from operations totaled $115 million for the six months ended June 30, 2011, and $31.1 million for the three months ended June 30, 2011.  Cash flow in the quarter was negatively impacted by a decrease in the medical claims payable liability due primarily to an increase in claims processing speed. Additionally, cash flow was negatively impacted by the normal occurrence of two estimated income tax payments during the second quarter.

Outlook

The Company's updated parameters associated with the full-year 2011 outlook can be found on page 11 of this release.  

The Company has raised its full-year 2011 health benefits ratio range to 83.1% – 84.1% compared to the previous range of 82.8% – 83.8%.  The change reflects the impact of rate renewals that are likely to be more modest than previously expected, retroactive premium reductions, and a slightly higher medical cost trend assumption in future quarters.  

In addition, the Company raised its full-year 2011 selling, general and administrative ratio range to 7.8% plus or minus 20 basis points from the previous expectation of 7.6% plus or minus 20 basis points to reflect incremental spending in support of the large number of potential expansion opportunities in both new and existing markets, including additional expenses to begin operations in Louisiana.  

Finally, the Company now expects that the net income margin for the full-year 2011 will be toward the upper-end of the Company's long-term net income margin range of 2.5% – 3.5%.

Second Quarter Earnings Call

Amerigroup senior management will discuss the Company's second quarter results on a conference call Friday, July 29, 2011 at 8:00 a.m. Eastern Time (ET).  The conference can be accessed by dialing 866-260-3161 (domestic) or 706-679-7245 (international) approximately ten minutes prior to the start time of the call.  A recording of the call may be accessed by dialing 800-642-1687 (domestic) or 706-645-9291 (international) and providing passcode 79572612.  The replay will be available shortly after the conclusion of the call until Friday, August 5, at 11:59 p.m. ET.  The conference call will also be available through the investors' page of the Company's web site, www.amerigroupcorp.com, or through www.earnings.com.  A 30-day replay of this webcast will be available on these web sites beginning approximately two hours following the conclusion of the live broadcast earnings conference call.

About Amerigroup Corporation

Amerigroup, a Fortune 500 Company, coordinates services for individuals in publicly funded healthcare programs. Serving approximately 2.0 million members in 11 states nationwide, Amerigroup accepts all eligible people regardless of age, sex, race or disability. The Company's product offerings do not utilize any individual underwriting nor deny coverage due to pre-existing medical conditions. Amerigroup is dedicated to offering real solutions that improve health care access and quality for its members, while proactively working to reduce the overall cost of care to taxpayers. Click here for more information about Amerigroup Corporation.

Forward-Looking Statements

This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the Securities and Exchange Commission's Fair Disclosure Regulation. This release contains certain ''forward-looking'' statements, including those with respect to the levels of rate renewals, medical cost trends, recovery of Georgia premium revenue, Louisiana operations, expansion opportunities and our 2011 outlook, that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements involve known and unknown risks and uncertainties that may cause our actual results in future periods to differ materially from those projected or contemplated in the forward-looking statements. These risks and uncertainties include, but are not limited to: our inability to manage medical costs; our inability to operate new products and markets at expected levels, including, but not limited to, profitability, membership and targeted service standards; local, state and national economic conditions, including their effect on the rate-setting process and timing of payments; the effect of government regulations and changes in regulations governing the healthcare industry, including the impact of recently enacted healthcare reform legislation; changes in Medicaid and Medicare payment levels and methodologies; increased use of services, increased cost of individual services, epidemics, pandemics, the introduction of new or costly treatments and technology, new mandated benefits, insured population characteristics and seasonal changes in the level of healthcare use; our ability to maintain and increase membership levels; our ability to enter into new markets or remain in existing markets; changes in market interest rates or any disruptions in the credit markets; our ability to maintain compliance with all minimum capital requirements; liabilities and other claims asserted against us; demographic changes; the competitive environment in which we operate; the availability and terms of capital to fund acquisitions, capital improvements and maintain capitalization levels required by state agencies; our ability to attract and retain qualified personnel; the unfavorable resolution of new or pending litigation; and catastrophes, including acts of terrorism or severe weather.

Investors should also refer to our annual report on Form 10-K for the year ended December 31, 2010 filed with the Securities and Exchange Commission ("SEC") and subsequent quarterly reports on Form 10-Q and current reports on Form 8-K filed with or furnished to the SEC, for a discussion of certain known risk factors that could cause our actual results to differ materially from our current estimates. Given these risks and uncertainties, we can give no assurances that any forward-looking statements will, in fact, transpire and, therefore, caution investors not to place undue reliance on them. We specifically disclaim any obligation to update or revise any forward-looking statements, whether as a result of new information, future developments or otherwise.  

AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED INCOME STATEMENTS

(dollars in thousands, except per share data)

(unaudited)










Three months ended


Six months ended


June 30,


June 30,


2011


2010


2011


2010









Revenues:








Premium

$1,523,433


$1,428,879


$3,059,228


$2,795,646

Investment income and other

4,001


8,634


8,121


13,516

Total revenues

1,527,434


1,437,513


3,067,349


2,809,162

Expenses:








Health benefits

1,281,760


1,176,445


2,538,722


2,318,017

Selling, general and administrative

122,289


108,189


238,748


225,612

Premium taxes

40,439


33,172


80,887


64,644

Depreciation and amortization

9,332


8,905


18,422


17,615

Interest

4,170


4,019


8,349


8,009

Total expenses

1,457,990


1,330,730


2,885,128


2,633,897

Income before income taxes

69,444


106,783


182,221


175,265

Income tax expense

25,150


39,570


67,450


65,870

Net income

$44,294


$67,213


$114,771


$109,395

















Diluted net income per share

$0.83


$1.31


$2.18


$2.14









Weighted average number of common shares and dilutive potential common shares outstanding

53,541,368


51,318,044


52,658,303


51,235,939




The following table sets forth selected operating ratios.  All ratios, with the exception of the health benefits ratio, are shown as a percentage of total revenues.


Three months ended


Six months ended


June 30,


June 30,


2011


2010


2011


2010

Premium revenue

99.7

%


99.4

%


99.7

%


99.5

%

Investment income and other

0.3



0.6



0.3



0.5


Total revenues

100.0

%


100.0

%


100.0

%


100.0

%

Health benefits [1]

84.1

%


82.3

%


83.0

%


82.9

%

Selling, general and administrative expenses

8.0

%


7.5

%


7.8

%


8.0

%

Income before income taxes

4.5

%


7.4

%


5.9

%


6.2

%

Net income

2.9

%


4.7

%


3.7

%


3.9

%













[1] The health benefits ratio is shown as a percentage of premium revenue because there is a direct relationship between the premium received and the health benefits provided.



The following table sets forth the approximate number of members the Company served in each state as of June 30, 2011 and 2010.  Because the Company receives two premiums for members that are both in the Medicare Advantage and Medicaid products, these members have been counted twice in the states where we offer both plans.




June 30,





2011


2010




Texas

593,000


539,000

[1]



Georgia

270,000


259,000




Florida

262,000


259,000




Maryland  

207,000


202,000




Tennessee

205,000


199,000




New Jersey

133,000


145,000




New York

109,000


111,000




Nevada

86,000


72,000




Ohio

55,000


58,000




Virginia

40,000


39,000




New Mexico

22,000


21,000




     Total  

1,982,000


1,904,000









[1] Membership includes approximately 14,000 members under an administrative services only (ASO) contract in 2010.  



The following table sets forth the approximate number of members in each of the Company's products as of June 30, 2011 and 2010.  Because the Company receives two premiums for members that are in both the Medicare Advantage and Medicaid products, these members have been counted in each product.


June 30,


Product

2011


2010


TANF (Medicaid)

1,405,000


1,337,000


CHIP

266,000


274,000


Aged, Blind and Disabled and Long-Term Care (Medicaid)

216,000


204,000

[1]

FamilyCare (Medicaid)

74,000


71,000


Medicare Advantage

21,000


18,000


Total

1,982,000


1,904,000












[1]Membership includes approximately 14,000 members under an ASO contract in 2010.



AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(dollars in thousands, except per share data)

(unaudited)


June 30,


December 31,


2011


2010







Assets

Current assets:




Cash and cash equivalents

$582,771


$763,946

Short-term investments  

272,113


230,007

Premium receivables  

114,819


83,203

Deferred income taxes  

28,008


28,063

Prepaid expenses, provider and other receivables and other

84,033


53,482

Total current assets

1,081,744


1,158,701





Long-term investments, including investments on deposit for licensure

980,937


754,004

Property, equipment and software, net

99,315


96,967

Goodwill

260,496


260,496

Other long-term assets  

13,109


13,220


$2,435,601


$2,283,388





Liabilities and Stockholders' Equity

Current liabilities:




Claims payable

$519,508


$510,675

Unearned revenue

104,213


103,067

Contractual refunds payable

66,865


44,563

Accounts payable, accrued expenses and other

204,380


192,536

Current portion of long-term convertible debt

251,432


-

Total current liabilities

1,146,398


850,841





Long-term convertible debt

-


245,750

Other long-term liabilities

23,667


21,160

Total liabilities

1,170,065


1,117,751





Stockholders’ equity:




Common stock, $.01 par value

567


554

Additional paid-in capital, net of treasury stock

280,213


300,453

Accumulated other comprehensive income

5,982


627

Retained earnings

978,774


864,003

Total stockholders’ equity

1,265,536


1,165,637


$2,435,601


$2,283,388



AMERIGROUP CORPORATION AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(dollars in thousands)

(unaudited)


Six months ended

June 30,


2011


2010



Cash flows from operating activities:




Net income

$114,771


$109,395

Adjustments to reconcile net income to net cash provided by




operating activities:




Depreciation and amortization

18,422


17,615

Loss on disposal of property, equipment and software

320


24

Deferred tax benefit

(144)


(1,972)

Compensation expense related to share-based payments

10,757


9,571

Convertible debt non-cash interest expense

5,682


5,323

Gain on sale of intangible assets

-


(4,000)

Other

7,263


4,189

Changes in assets and liabilities (decreasing) increasing cash




flows from operations:




Premium receivables

(31,616)


(10,140)

Prepaid expenses, provider and other receivables and other




current assets

(28,722)


(6,138)

Other assets

(2,106)


(55)

Claims payable

8,833


(3,433)

Accounts payable, accrued expenses, contractual refund payable




and other current liabilities

10,653


41,371

Unearned revenue

1,146


(50,474)

Other long-term liabilities

(606)


(1,714)

Net cash provided by operating activities

114,653


109,562





Cash flows from investing activities:




Purchase of investments, net

(257,487)


(150,908)

Purchase of property, equipment and software

(20,170)


(13,508)

Purchase of investments on deposit for licensure, net

(10,232)


(12,516)

Proceeds from sale of intangible assets

-


4,000

Purchase of contract rights and other related assets

-


(13,420)

Net cash used in investing activities

(287,889)


(186,352)





Cash flows from financing activities:




Change in bank overdrafts

16,262


13,361

Proceeds and tax benefits from exercise of stock options




and other, net

55,796


11,023

Repurchase of common stock shares

(79,997)


(43,676)

Net cash used in financing activities

(7,939)


(19,292)

Net decrease in cash and cash equivalents

(181,175)


(96,082)

Cash and cash equivalents at beginning of period

763,946


505,915

Cash and cash equivalents at end of period

$582,771


$409,833



AMERIGROUP CORPORATION AND SUBSIDIARIES





Components of the Change in Medical Claims Payable

(dollars in thousands)






Six months ended


June 30,


2011


2010

Medical claims payable, beginning of period

$510,675


$529,036





Health benefits expenses incurred during period:




Related to current year

2,613,310


2,408,166

Related to prior years

(74,588)


(90,149)

Total incurred

2,538,722


2,318,017





Health benefits payments during period:




Related to current year

2,168,850


1,960,389

Related to prior years

361,039


361,061

Total payments

2,529,889


2,321,450





Medical claims payable, end of period

$519,508


$525,603





Health benefits expenses incurred during both periods were reduced for amounts related to prior years.  The amounts related to prior years include the impact of amounts previously included in the liability to establish it at a level sufficient under moderately adverse conditions that were not needed and the reduction in health benefits expenses due to revisions to prior estimates.



2011 Outlook







Current Parameters



Previous Parameters


As of July 29, 2011



As of April 29, 2011

Total revenues percentage growth

upper single digits



upper single digits

Health benefits ratio

83.1% - 84.1%



82.8% - 83.8%

Selling, general & administrative ratio

7.8% plus or minus 20 bps



7.6% plus or minus 20 bps

Net income margin

Upper-end of the range of 2.5% – 3.5%



Upper-end to above the range of 2.5% – 3.5%

Diluted shares outstanding

53 – 54 million



53 – 54 million



CONTACTS:
Investors:  Julie Loftus Trudell
Amerigroup Corporation
Senior Vice President, Investor Relations
(757) 321-3597
[email protected]

News Media: Maureen C. McDonnell
Amerigroup Corporation
Vice President, External Communications
(757) 473-2731
[email protected]  

SOURCE Amerigroup Corporation

Suggested Articles

Microsoft is warning hospitals that sophisticated ransomware attacks are trying to exploit remote workers to gain access to their networks.

As more Americans lose their jobs amid the COVID-19 pandemic, the number of people without health insurance is also expected to rise. 

There could be imminent shortages of antimalarial drugs and antibiotics that are critical to providing care for COVID-19 patients.